Servier: Precision Approach To Immunotherapy Will Define New Oncology Era
Executive Summary
Two oncology chiefs from the French firm talked to Scrip about how its pipeline echoes the emerging intersection between precision medicine and immuno-oncology and how biology is taking precedence over technology in cancer R&D.